Located in Mountain View California MAP Pharmaceuticals Inc. uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety efficacy and commercialization history. The Company has several proprietary product candidates in clinical development that address large market opportunities including the two most advanced product candidates: a proprietary formulation of nebulized budesonide for the potential treatment of children with asthma and a proprietary formulation of inhaled dihydroergotamine for the potential treatment of migraine. Map Pharmaceuticals, Inc. has a market cap of $203.3 million; its shares were traded at around $8.33 .
MAPP is in the portfolios of George Soros of Soros Fund Management LLC.
Insiders' Positions with MAPP
- Sell:: CFO Christopher Y Chai sold 10,000 shares of MAPP stock on 10/01/2009 at the average price of 10.26, the price of the stock has decreased by 18.81% since
Insiders' Positions with MAPP
- Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 4,500 shares of MAPP stock on 10/01/2009 at the average price of 10.2, the price of the stock has decreased by 18.33% since
- Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 4,500 shares of MAPP stock on 09/08/2009 at the average price of 10.03, the price of the stock has decreased by 16.95% since
- Sell:: See footnote 1 Capital, L.l.c. Firstmark sold 9,700 shares of MAPP stock on 07/15/2009 at the average price of 10.56, the price of the stock has decreased by 21.12% since
- Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 25,000 shares of MAPP stock on 07/10/2009 at the average price of 10.16, the price of the stock has decreased by 18.01% since
- Sell:: See Footnote 1 Capital, L.l.c. Firstmark sold 2,400 shares of MAPP stock on 07/02/2009 at the average price of 12, the price of the stock has decreased by 30.58% since
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |